Clinical Trial Update: Real World Study to Describe the Effectiveness and Safety of Teprotumumab Among Thyroid Eye Disease Patients

View source ↗

Summary

A real-world study completed to evaluate the effectiveness and safety of Teprotumumab in patients with Thyroid Eye Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Eye Disease

Drugs mentioned

• Tepezia (Teprotumumab)

Snippet

Sponsor: Amgen | Conditions: Thyroid Eye Disease | Status: COMPLETED